Replies to post #184136 on PCT Ltd (PCTL)

[Xfree]

Any ideas on why it takes so long to have revenues from G&O given that the current test will be completed this month?

[cuggegrosse]

Thanks,that's precisely what Art said during his last podcast

[skitahoe]

DE,

If earnings fall into the $5 to $10 million for the year, based on the current O/S, we're speaking of roughly $.01 a share. While this may not sound like much, if we're clearly growing each quarter it could justify a P/E of 30, i.e. a share price of about $.30. Even with a P/E of 10 we'd be at a dime, a nice multiple of where we began the year.

What I'm not seeing here are people declaring we'll be on the Nasdaq by the end of the year, and other similar claims, and frankly it's refreshing. Better to be realistic about what we may see. If the earnings truly go dramatically higher, perhaps $.50 will be in play. If it were, by next year discussions of the Nasdaq could be warranted by the end of 2023, but that would be outstanding growth as long as a reverse split wasn't employed. Frankly, while I don't like reverse splits, if the company built the share price to $1, I wouldn't fight say a 1 for 5 which should qualify us for the Nasdaq. What I'd never support would be extremes like 1 for 100 or frankly anything above 1 for 10. A $1 share price could put us on the AMEX, and I believe that would be a strong move, but it should be done without a R/S.

Gary

[AISI304]

Very nice, DE! And our CFO is conservative with any estimates.
Now, with so much going on, inked deals will drive the price up.

GL, health to you and all!

Catalysts to deals!

O&G 'er up!

V'room!

$PCTL

DesertEagle Tuesday, 01/11/22 07:44:46 PM
Re: cuggegrosse post# 184131 0.620
Post # 184136 of 184163

$PCTL this is what I remember...

1. The 5M to 10M projection for 2022 is conservative
2. Revenues increasing to over 50M in 5 years
3. PCTL should see positive cash flow in Q1 2022
4. UK revenue expected end of Q1 beginning of Q2 2022
5. Top line growth beginning end of January and continue to grow with majority of revenue from Healthcare & Fluid
6. In 2022 concentrating on 4 divisions... Healthcare, Fluids, Oil & Gas and Agriculture including Cannabis
7. Revenue to begin from Oil & Gas 3Q/4Q 2022